RCT NO. 1 – EST vs. EPCS RCT NO. 2 – EPCS vs. TIPS
  EST (n = 106) EPCS (n = 105)   EPCS (n = 76) TIPS (n = 78)  
Hours Median/Mean Range Median/Mean Range P Value Median/Mean Range Median/Mean Range P Value
Onset bleeding to study entry 12/19.8 0-144 16/19 0-95 0.30 20/25.4 0-112 17/24.2 0.5-84 0.56
Onset bleeding to primary therapy 15/23.3 3-147 19/21.5 2.6-100 0.056 27.5/35.9 8-131.7 34.2/39.0 11.1-99.4 0.08
Study entry to primary therapy
n >8 h
% >8 h
2.5/3.1
0
0
0.8-8 3.4/4.4
3
2.9
1.4-24.3 <0.001* 9.5/10.2
3
3.9
2-30.1 14.6/14.7
76 (97)
68 (87)
2.3-38.4 <0.001*
1.0
0.5
Transfer patients, n (%)
Onset of bleeding to entry in referring hospital
Entry into referring hospital to study entry

71 (67)
4.05/10.4
7.2/11.8
0-127
1.5-53

80 (76)
3.75/9.7
8.4/11.6
0-83.6
0-53

0.17
0.92
0.56

63 (83)
6.3/11.9
13.0/18.4

0-120
2.2-110

68 (87)
5.7/9.8
10.5/16.4
0-62
2.6-65.3

0.5
0.72
0.42
Last observation of bleeding to study entry
≤4 h, % of group
>4 h, % of group
0/1.9
84
16
0-32 0/2.5
84
16
0-30 0.76
0.94
1.00
0/1.6
67 (88)
9 (12)
0-32 0/3.6
63 (81)
15 (19)
0-84 0.35
0.27
*Statistically significant difference
EPCS-Emergency Portacaval Shunt; EST- Endoscopic Sclerotherapy; TIPS-Transjugular Intrahepatic Portosystemic Shunt
Table 3: Rapidity of therapy for patients with cirrhosis and bleeding esophageal varices in RCT No. 1 (endoscopic sclerotherapy versus emergency portacaval shunt) and RCT No. 2 (TIPS versus emergency portacaval shunt).